Puma Biotechnology (NASDAQ:PBYI – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a report released on Wednesday. Separately, HC Wainwright restated a “buy” rating and issued a $7.00 price objective on shares of Puma Biotechnology in a report on Monday, June 3rd. Read Our […]
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
LA500 2024: Alan Auerbach labusinessjournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from labusinessjournal.com Daily Mail and Mail on Sunday newspapers.
Puma Biotechnology to Join Russell 3000 Index marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Puma Biotechnology, Inc. , a biopharmaceutical company, announced the release of abstracts on alisertib to be presented at the 2024 American Society of Clinical Oncology Annual Meeting. The ASCO.